Grape Seed Extract

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

葡萄籽提取物是葡萄植物葡萄种子的渗出物，由油和次级植物代谢物（生物类黄酮和多酚）组成，具有重要的药用特性。

Grape Seed Extract is exudate from seeds of the grape plant Vitis vinifera, composed of oils and secondary plant metabolites (BIOFLAVONOIDS and polyphenols) credited with important medicinal properties.

Grape seed extract (25-100 μg/mL; 12-48 hours) inhibits growth and induces death in human colorectal cancer cells.Grape seed extract (25-100 μg/mL; 12-24 hours) modulates the protein levels of cell cycle regulatory molecules in HT29 and LoVo cells.Grape seed extract (25-100 μg/mL; 24 hours) causes apoptotic cell death of human colorectal cancer cells. TCell Proliferation Assay Cell Line:HT29 cells, LoVo cells Concentration:25 μg/mL, 50 μg/mL, 100 μg/mL Incubation Time:12 hours, 24 hours, 48 hours Result:Inhibited cell growth in a dose- and a time-dependent manner.Cell Cycle Analysis Cell Line:HT29 cells, LoVo cells Concentration:25 μg/mL, 50 μg/mL, 100 μg/mL Incubation Time:12 hours, 24 hours, 48 hours Result:Induced cell cycle arrest (a marked increase in Cip1/p21protein level and a decrease in G 1 phase^associated cyclins and cyclin-dependentkinases).Western Blot Analysis Cell Line:HT29 cells, LoVo cells Concentration:25 μg/mL, 50 μg/mL, 100 μg/mL Incubation Time:12 hours, 24 hours Result:Modulates the protein levels of CDKIs, CDKs, and cyclins.Apoptosis Analysis Cell Line:HT29 cells, LoVo cells Concentration:25 μg/mL, 50 μg/mL, 100 μg/mL Incubation Time:24 hours Result:Showed a significant dose-dependent increase in apoptotic cell population in HT29 cells at 50 μg/mL and 100 μg/mL; all three Concentrations caused a dose-dependent increase in apoptotic cells.

Grape seed extract (200 mg/kg; i.g.; 5 days/wk; for 8 weeks) inhibits HT29 colon carcinoma tumor xenograft growth in athymic nude mice.Grape seed extract inhibits cell proliferation but increases apoptotic cell death in tumors. Grape seed extract enhances Cip1/p21protein levels and poly(ADP-ribose) poly-merase cleavage in tumors. Animal Model:Athymic male nu/nu mice, with human colon carcinoma HT29 tumor xenograft Dosage: 200 mg/kg Administration:Oral gavage, 5 days/wk, for 8 weeks Result:Showed time-dependent inhibition of tumor growth.

——

Apoptosis

NF-κB

Others

Others-Field

——

84929-27-1

590.58

C32H30O11

>98% (HPLC)

In Vitro:?DMSO : 6 mg/mL

Cc1cc(O)c([C@H]2[C@H](O)[C@H](Oc3cc(O)cc(O)c23)c2ccc(O)c(O)c2)c2O[C@H](c3ccc(O)c(O)c3)[C@](C)(O)Cc12

——

(-20℃)

With Ice Pack

≥ 2 years